Effect of cholecalciferol on parathyroid hormone and vitamin D levels in chronic kidney disease

Minerva Urologica e Nefrologica

Volumn 63, Issue 4, 2011, Pages 287-292

  Basturk, T ^a   Unsal, A ^b   Ulas, T ^b  

^a Bagcilar Education and Research Hospital ^*  (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Cholecalciferol; Kidney failure, chronic; Parathyroid hormone; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; PARATHYROID HORMONE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MALE; PROSPECTIVE STUDY; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL;

ADMINISTRATION, ORAL; ADULT; AGED; BONE DENSITY CONSERVATION AGENTS; CHOLECALCIFEROL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS; HUMANS; HYPERPARATHYROIDISM; HYPERTENSION; MALE; MIDDLE AGED; PARATHYROID HORMONE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TREATMENT OUTCOME; VITAMIN D;

EID: 83755184301     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q et al. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 2005;45:1026-33. (Pubitemid 40806515)
2. Block GA, Klassen PS, Lazarus LM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-18. (Pubitemid 39031360)
3. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42:S1-201.
4. Johal M, Levin A. Vitamin D and parathyroid hormone in general populations. Understandings in 2009 and Applications to Chronic Kidney Disease. Clin J Am Soc Nephrol 2009;4:1508-14.
5. Andrew SL, Josef C, Ethan B, Annamaria TK, Adeera L, Michael WS et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Ann Intern Med 2003;139:605.
6. Tonelli M. Vitamin D in patients with chronic kidney disease: nothing new under the sun. Ann Intern Med 2007;147:880-1. (Pubitemid 351664429)
7. Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004;89:5387-91. (Pubitemid 39518413)
8. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998;68:854-8. (Pubitemid 28471068)
9. Pesenson A, Maski M. Prevalence of 25-OH Vitamin D (25-OH) Deficiency in Patients (Pts) with Chronic Kidney Disease (CKD) and Effects of Correction Following KDOQI Guidelines [abstract]. J Am Soc Nephrol 2006;(Suppl 1).
10. Zisman A, Hristova M, Ho LT, Sprague SM. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 2007;27:36-43. (Pubitemid 46364539)
11. Rucker D, Tonelli M, Coles MG, Yoo S, Young K, McMahon AW. Vitamin D insufficiency and treatment with oral vitamin D3 in northern-dwelling patients with chronic kidney disease. J Nephrol 2009;22:75-82.
12. Chandra P, Binongo JN, Ziegler TR, Schlanger LE, Wang W, Someren JT et al. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study. Endocr Pract 2008;14:10-7.
13. Dogan E, Erkoc R, Sayarlioglu H, Soyoral Y, Dulger H. Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and 4 chronic kidney diseases patients. Ren Fail 2008;30:407-10. (Pubitemid 351868693)
14. Bouillon RA, Auwerx JH, Lissens WD, Pelemans WK. Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency. Am J Clin Nutr 1987;45:755-63. (Pubitemid 17077921)
15. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007;71:31-8. (Pubitemid 44967731)
16. Zehnder D, Landray MJ, Wheeler DC, Fraser W, Blackwell L, Nuttall S et al. Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study. Nephron Clin Pract 2007;107:c109-16. (Pubitemid 350073616)
17. Olgaard K, Lewin E. Use (or misuse) of vitamin D treatment in CKD and dialysis patients: A recent meta-analysis on vitamin D compounds in chronic kidney disease. Nephrol Dial Transplant 2008;23:1786-9.